Innovation in modelling Placenta for Maternal and Fetal Health (iPLACENTA) (joint with Mimetas BV, St George's Medical School, University College Cork, Universita Degli Studi di Torino, Institut National de le Sante et de la Recherche Medicale, Universitaet Rostock, Fundacion Para le Investigacion del Hospital Universitario La Fe De La Comunidad Valencia, Aston University, Katholieke Universiteit Leuven, Universiteit Maastricht)

Activity: Other activity typesFunding - grants and income which support research related activities

Description

Objective
Inovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a Euro3.9 million funded European Training Network (ETN), coordinated by Dr Colin Murdoch at University of Dundee.
Iplacenta will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. 
“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . In iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together three different businesses; Mimetas (MIM) (organ-on-a-chip developer) as a beneficiary, and Moor, a clinical-technology specialist, and industrial global brand FujifFilm VisualSonics (FUJ) as partners. Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.

Project Information

iPLACENTA
Grant agreement ID: 765274

Funded under
EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost
€ 3,929,698,80

Coordinated by
University of Dundee
United Kingdom
Period1 Mar 201831 May 2022
Held atEuropean Union, Belgium
Degree of RecognitionInternational